Oligonucleotide Synthesis Market (2026 - 2033) Size, Share & Trends Analysis Report By Product & Service (Oligonucleotides, Reagents, Services, Equipment/Synthesizer), By Application (PCR Primers, Sequencing, DNA Microarrays), By End Use, By Region, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation and Scope
                        1.1.1. Segment Definitions
                            1.1.1.1. Product & Service Segment
                            1.1.1.2. Application Segment
                            1.1.1.3. End Use Segment
                    1.2. Regional Scope
                    1.3. Estimates and Forecast Timeline
                    1.4. Objective
                        1.4.1. Objective 1
                        1.4.2. Objective2
                    1.5. Research Methodology
                    1.6. Information Procurement
                        1.6.1. Purchased Database
                        1.6.2. GVR’s Internal Database
                        1.6.3. Secondary Sources
                        1.6.4. Primary Research
                    1.7. Information or Data Analysis:
                        1.7.1. Data Analysis Models
                    1.8. Market Formulation & Validation
                    1.9. Model Details
                        1.9.1. Commodity Flow Analysis
                    1.10. List of Secondary Sources
                    1.11. List of Abbreviations
Chapter 2. Executive Summary
                    2.1. Market Snapshot
                    2.2. Segment Snapshot
                    2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent Market Outlook
                        3.1.2. Related/Ancillary Market Outlook
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                            3.2.1.1. Growth of nucleic acid–based therapies
                            3.2.1.2. Rising use in molecular diagnostics
                        3.2.2. Market Restraint Analysis
                            3.2.2.1. High cost associated with genomics research
                    3.3. Industry Analysis Tools
                        3.3.1. Porter’s Five Forces Analysis
                        3.3.2. PESTEL Analysis
Chapter 4. Product & Service Business Analysis
                    4.1. Product & Service Segment Dashboard
                    4.2. Oligonucleotide Synthesis Market: Product & Service Movement Analysis
                    4.3. Oligonucleotides
                        4.3.1. Global oligonucleotides market, 2021 - 2033 (USD million)
                        4.3.2. Product type
                            4.3.2.1. Global product type oligonucleotides market, 2021 - 2033 (USD million)
                            4.3.2.2. DNA
                                4.3.2.2.1. Global DNA market, 2021 - 2033 (USD million)
                                4.3.2.2.2. Technology
                                    4.3.2.2.2.1. Global technology oligonucleotides market, 2021 - 2033 (USD million)
                                    4.3.2.2.2.2. Column-based
                                        4.3.2.2.2.2.1. Global column-based market, 2021 - 2033 (USD million)
                                    4.3.2.2.2.3. Array-based
                                        4.3.2.2.2.3.1. Global array-based market, 2021 - 2033 (USD million)
                            4.3.2.3. RNA
                                4.3.2.3.1. Global RNA market, 2021 - 2033 (USD million)
                                4.3.2.3.2. Technology
                                    4.3.2.3.2.1. Global technology oligonucleotides market, 2021 - 2033 (USD million)
                                    4.3.2.3.2.2. Column-based
                                        4.3.2.3.2.2.1. Global column-based market, 2021 - 2033 (USD million)
                                    4.3.2.3.2.3. Array-based
                                        4.3.2.3.2.3.1. Global array-based market, 2021 - 2033 (USD million)
                                4.3.2.3.3. Type
                                    4.3.2.3.3.1. Global type oligonucleotides market, 2021 - 2033 (USD million)
                                    4.3.2.3.3.2. Short RNA Oligos (<65 nt)
                                        4.3.2.3.3.2.1. Global short RNA oligos (<65 nt) market, 2021 - 2033 (USD million)
                                    4.3.2.3.3.3. Long RNA Oligos (>65 nt)
                                        4.3.2.3.3.3.1. Global long RNA oligos (>65 nt) market, 2021 - 2033 (USD million)
                                    4.3.2.3.3.4. CRISPR (sgRNA)
                                        4.3.2.3.3.4.1. Global CRISPR (sgRNA) market, 2021 - 2033 (USD million)
                    4.4. Equipment/Synthesizer
                        4.4.1. Global equipment/synthesizer market, 2021 - 2033 (USD million)
                    4.5. Reagents
                        4.5.1. Global reagents market, 2021 - 2033 (USD million)
                    4.6. Services
                        4.6.1. Global Services market, 2021 - 2033 (USD million)
                        4.6.2. DNA
                            4.6.2.1. Global DNA market, 2021 - 2033 (USD million) market, 2021 - 2033 (USD million)
                            4.6.2.2. Custom Oligo Synthesis Services
                                4.6.2.2.1. Global custom oligo synthesis services market, 2021 - 2033 (USD million)
                                4.6.2.2.2. 25 nmol
                                    4.6.2.2.2.1. Global 25 nmol market, 2021 - 2033 (USD million)
                                4.6.2.2.3. 50 nmol
                                    4.6.2.2.3.1. Global 50 nmol market, 2021 - 2033 (USD million)
                                4.6.2.2.4. 200 nmol
                                    4.6.2.2.4.1. Global 200 nmol market, 2021 - 2033 (USD million)
                                4.6.2.2.5. 1000 nmol
                                    4.6.2.2.5.1. Global 1000 nmol market, 2021 - 2033 (USD million)
                                4.6.2.2.6. 10000 nmol
                                    4.6.2.2.6.1. Global 10000 nmol market, 2021 - 2033 (USD million)
                            4.6.2.3. Modification Services
                                4.6.2.3.1. Global modification services market, 2021 - 2033 (USD million)
                            4.6.2.4. Purification Services
                                4.6.2.4.1. Global purification services market, 2021 - 2033 (USD million)
                        4.6.3. RNA
                            4.6.3.1. Global RNA market, 2021 - 2033 (USD million)
                            4.6.3.2. Global DNA market, 2021 - 2033 (USD million) market, 2021 - 2033 (USD million)
                            4.6.3.3. Custom Oligo Synthesis Services
                                4.6.3.3.1. Global custom oligo synthesis services market, 2021 - 2033 (USD million)
                                4.6.3.3.2. 25 nmol
                                    4.6.3.3.2.1. Global 25 nmol market, 2021 - 2033 (USD million)
                                4.6.3.3.3. 50 nmol
                                    4.6.3.3.3.1. Global 50 nmol market, 2021 - 2033 (USD million)
                                4.6.3.3.4. 200 nmol
                                    4.6.3.3.4.1. Global 200 nmol market, 2021 - 2033 (USD million)
                                4.6.3.3.5. 1000 nmol
                                    4.6.3.3.5.1. Global 1000 nmol market, 2021 - 2033 (USD million)
                                4.6.3.3.6. 10000 nmol
                                    4.6.3.3.6.1. Global 10000 nmol market, 2021 - 2033 (USD million)
                            4.6.3.4. Modification Services
                                4.6.3.4.1. Global modification services market, 2021 - 2033 (USD million)
                            4.6.3.5. Purification Services
                                4.6.3.5.1. Global purification services market, 2021 - 2033 (USD million)
Chapter 5. Application Business Analysis
                    5.1. Application Segment Dashboard
                    5.2. Oligonucleotide Synthesis Market: Application Movement Analysis
                    5.3. PCR Primers
                        5.3.1. Global PCR primers market, 2021 - 2033 (USD million)
                    5.4. PCR Assays and Panels
                        5.4.1. Global PCR assays and panels market, 2021 - 2033 (USD million)
                    5.5. Sequencing
                        5.5.1. Global sequencing market, 2021 - 2033 (USD million)
                    5.6. DNA Microarrays
                        5.6.1. Global DNA microarrays market, 2021 - 2033 (USD million)
                    5.7. Fluorescence In Situ Hybridization (FISH)
                        5.7.1. Global Fluorescence In Situ Hybridization (FISH) market, 2021 - 2033 (USD million)
                    5.8. Antisense Oligonucleotides
                        5.8.1. Global antisense oligonucleotides market, 2021 - 2033 (USD million)
                    5.9. Other Applications
                        5.9.1. Global other applications market, 2021 - 2033 (USD million)
Chapter 6. End Use Business Analysis
                    6.1. End Use Segment Dashboard
                    6.2. Oligonucleotide Synthesis Market: End Use Movement Analysis
                    6.3. Academic Research Institutes
                        6.3.1. Global academic research institutes market, 2021 - 2033 (USD million)
                    6.4. Diagnostic Laboratories
                        6.4.1. Global diagnostic laboratories market, 2021 - 2033 (USD million)
                    6.5. Pharmaceutical and Biotechnology Companies
                        6.5.1. Global pharmaceutical and biotechnology companies market, 2021 - 2033 (USD million)
Chapter 7. Regional Business Analysis
                    7.1. Oligonucleotide Synthesis Market Share By Region, 2025 & 2033
                    7.2. North America
                        7.2.1. North America Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
                        7.2.2. U.S.
                            7.2.2.1. Key Country Dynamics
                            7.2.2.2. Competitive Scenario
                            7.2.2.3. Regulatory Framework
                            7.2.2.4. U.S. Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
                        7.2.3. Canada
                            7.2.3.1. Key Country Dynamics
                            7.2.3.2. Competitive Scenario
                            7.2.3.3. Regulatory Framework
                            7.2.3.4. Canada Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
                        7.2.4. Mexico
                            7.2.4.1. Key Country Dynamics
                            7.2.4.2. Competitive Scenario
                            7.2.4.3. Regulatory Framework
                            7.2.4.4. Mexico Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
                    7.3. Europe
                        7.3.1. Europe Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
                        7.3.2. UK
                            7.3.2.1. Key Country Dynamics
                            7.3.2.2. Competitive Scenario
                            7.3.2.3. Regulatory Framework
                            7.3.2.4. UK Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
                        7.3.3. Germany
                            7.3.3.1. Key Country Dynamics
                            7.3.3.2. Competitive Scenario
                            7.3.3.3. Regulatory Framework
                            7.3.3.4. Germany Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
                        7.3.4. France
                            7.3.4.1. Key Country Dynamics
                            7.3.4.2. Competitive Scenario
                            7.3.4.3. Regulatory Framework
                            7.3.4.4. France Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
                        7.3.5. Italy
                            7.3.5.1. Key Country Dynamics
                            7.3.5.2. Competitive Scenario
                            7.3.5.3. Regulatory Framework
                            7.3.5.4. Italy Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
                        7.3.6. Spain
                            7.3.6.1. Key Country Dynamics
                            7.3.6.2. Competitive Scenario
                            7.3.6.3. Regulatory Framework
                            7.3.6.4. Spain Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
                        7.3.7. Denmark
                            7.3.7.1. Key Country Dynamics
                            7.3.7.2. Competitive Scenario
                            7.3.7.3. Regulatory Framework
                            7.3.7.4. Denmark Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
                        7.3.8. Sweden
                            7.3.8.1. Key Country Dynamics
                            7.3.8.2. Competitive Scenario
                            7.3.8.3. Regulatory Framework
                            7.3.8.4. Sweden Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
                        7.3.9. Norway
                            7.3.9.1. Key Country Dynamics
                            7.3.9.2. Competitive Scenario
                            7.3.9.3. Regulatory Framework
                            7.3.9.4. Norway Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
                    7.4. Asia Pacific
                        7.4.1. Asia Pacific Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
                        7.4.2. Japan
                            7.4.2.1. Key Country Dynamics
                            7.4.2.2. Competitive Scenario
                            7.4.2.3. Regulatory Framework
                            7.4.2.4. Japan Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
                        7.4.3. China
                            7.4.3.1. Key Country Dynamics
                            7.4.3.2. Competitive Scenario
                            7.4.3.3. Regulatory Framework
                            7.4.3.4. China Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
                        7.4.4. India
                            7.4.4.1. Key Country Dynamics
                            7.4.4.2. Competitive Scenario
                            7.4.4.3. Regulatory Framework
                            7.4.4.4. India Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
                        7.4.5. Australia
                            7.4.5.1. Key Country Dynamics
                            7.4.5.2. Competitive Scenario
                            7.4.5.3. Regulatory Framework
                            7.4.5.4. Australia Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
                        7.4.6. Thailand
                            7.4.6.1. Key Country Dynamics
                            7.4.6.2. Competitive Scenario
                            7.4.6.3. Regulatory Framework
                            7.4.6.4. Thailand Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
                        7.4.7. South Korea
                            7.4.7.1. Key Country Dynamics
                            7.4.7.2. Competitive Scenario
                            7.4.7.3. Regulatory Framework
                            7.4.7.4. South Korea Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
                    7.5. Latin America
                        7.5.1. Latin America Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
                        7.5.2. Brazil
                            7.5.2.1. Key Country Dynamics
                            7.5.2.2. Competitive Scenario
                            7.5.2.3. Regulatory Framework
                            7.5.2.4. Brazil Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
                        7.5.3. Argentina
                            7.5.3.1. Key Country Dynamics
                            7.5.3.2. Competitive Scenario
                            7.5.3.3. Regulatory Framework
                            7.5.3.4. Argentina Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
                    7.6. MEA
                        7.6.1. MEA Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
                        7.6.2. South Africa
                            7.6.2.1. Key Country Dynamics
                            7.6.2.2. Competitive Scenario
                            7.6.2.3. Regulatory Framework
                            7.6.2.4. South Africa Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
                        7.6.3. Saudi Arabia
                            7.6.3.1. Key Country Dynamics
                            7.6.3.2. Competitive Scenario
                            7.6.3.3. Regulatory Framework
                            7.6.3.4. Saudi Arabia Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
                        7.6.4. UAE
                            7.6.4.1. Key Country Dynamics
                            7.6.4.2. Competitive Scenario
                            7.6.4.3. Regulatory Framework
                            7.6.4.4. UAE Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
                        7.6.5. Kuwait
                            7.6.5.1. Key Country Dynamics
                            7.6.5.2. Competitive Scenario
                            7.6.5.3. Regulatory Framework
                            7.6.5.4. Kuwait Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
                    8.1. Company Categorization
                    8.2. Strategy Mapping
                    8.3. Company Market Share Analysis, 2025
                    8.4. Company Profiles/Listing
                        8.4.1. Thermo Fisher Scientific Inc.
                            8.4.1.1. Overview
                            8.4.1.2. Financial Performance
                            8.4.1.3. Product Benchmarking
                            8.4.1.4. Strategic Initiatives
                        8.4.2. Merck KGaA
                            8.4.2.1. Overview
                            8.4.2.2. Financial Performance
                            8.4.2.3. Product Benchmarking
                            8.4.2.4. Strategic Initiatives
                        8.4.3. Danaher
                            8.4.3.1. Overview
                            8.4.3.2. Financial Performance
                            8.4.3.3. Product Benchmarking
                            8.4.3.4. Strategic Initiatives
                        8.4.4. Revvity Discovery Limited
                            8.4.4.1. Overview
                            8.4.4.2. Financial Performance
                            8.4.4.3. Product Benchmarking
                            8.4.4.4. Strategic Initiatives
                        8.4.5. Agilent Technologies, Inc.
                            8.4.5.1. Overview
                            8.4.5.2. Financial Performance
                            8.4.5.3. Product Benchmarking
                            8.4.5.4. Strategic Initiatives
                        8.4.6. Bio-Synthesis, Inc.
                            8.4.6.1. Overview
                            8.4.6.2. Product Benchmarking
                            8.4.6.3. Strategic Initiatives
                        8.4.7. Kaneka Eurogentec S.A.
                            8.4.7.1. Overview
                            8.4.7.2. Product Benchmarking
                            8.4.7.3. Strategic Initiatives
                        8.4.8. LGC Biosearch Technologies
                            8.4.8.1. Overview
                            8.4.8.2. Financial Performance
                            8.4.8.3. Product Benchmarking
                            8.4.8.4. Strategic Initiatives
                        8.4.9. Biolegio
                            8.4.9.1. Overview
                            8.4.9.2. Product Benchmarking
                            8.4.9.3. Strategic Initiatives
                        8.4.10. Twist Bioscience
                            8.4.10.1. Overview
                            8.4.10.2. Financial Performance
                            8.4.10.3. Product Benchmarking
                            8.4.10.4. Strategic Initiatives

List of Tables

Table 1 Global oligonucleotide synthesis market, by region, 2021 - 2033 (USD Million)
Table 2 Global oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
Table 3 Global oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
Table 4 Global oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
Table 5 North America oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
Table 6 North America oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
Table 7 U.S. oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
Table 8 U.S. oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
Table 9 U.S. oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
Table 10 Canada oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
Table 11 Canada oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
Table 12 Canada oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
Table 13 Mexico oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
Table 14 Mexico oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
Table 15 Mexico oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
Table 16 Europe oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
Table 17 Europe oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
Table 18 Europe oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
Table 19 UK oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
Table 20 UK oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
Table 21 UK oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
Table 22 Germany oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
Table 23 Germany oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
Table 24 Germany oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
Table 25 France oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
Table 26 France oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
Table 27 France oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
Table 28 Italy oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
Table 29 Italy oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
Table 30 Italy oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
Table 31 Spain oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
Table 32 Spain oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
Table 33 Spain oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
Table 34 Denmark oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
Table 35 Denmark oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
Table 36 Denmark oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
Table 37 Sweden oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
Table 38 Sweden oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
Table 39 Sweden oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
Table 40 Norway oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
Table 41 Norway oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
Table 42 Norway oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
Table 43 Asia Pacific oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
Table 44 Asia Pacific oligonucleotide synthesis market, by application, 2021 - 2033 (USD Millon)
Table 45 Asia Pacific oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Millon)
Table 46 Japan oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
Table 47 Japan oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
Table 48 Japan oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
Table 49 China oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
Table 50 China oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
Table 51 China oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
Table 52 India oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
Table 53 India oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
Table 54 India oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
Table 55 Australia oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
Table 56 Australia oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
Table 57 Australia oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
Table 58 South Korea oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
Table 59 South Korea oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
Table 60 South Korea oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
Table 61 Thailand oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
Table 62 Thailand oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
Table 63 Thailand oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
Table 64 Latin America oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
Table 65 Latin America oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
Table 66 Latin America oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
Table 67 Brazil oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
Table 68 Brazil oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
Table 69 Brazil oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
Table 70 Argentina oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
Table 71 Argentina oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
Table 72 Argentina oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
Table 73 Middle East & Africa oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
Table 74 Middle East & Africa oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
Table 75 Middle East & Africa oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
Table 76 South Africa oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
Table 77 South Africa oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
Table 78 South Africa oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
Table 79 Saudi Arabia oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
Table 80 Saudi Arabia oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
Table 81 Saudi Arabia oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
Table 82 UAE oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
Table 83 UAE oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
Table 84 UAE oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
Table 85 Kuwait oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
Table 86 Kuwait oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
Table 87 Kuwait oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)

List of Figures

Fig. 1 Oligonucleotide synthesis market segmentation
Fig. 2 Data analysis models
Fig. 3 Market formulation and validation
Fig. 4 Data validating & publishing
Fig. 5 Market research process
Fig. 6 Information procurement
Fig. 7 Primary research
Fig. 8 Value-chain-based sizing & forecasting
Fig. 9 QFD modelling for market share assessment
Fig. 10 Market formulation & validation
Fig. 11 Commodity flow analysis
Fig. 12 Market outlook
Fig. 13 Segment snapshot
Fig. 14 Competitive landscape snapshot
Fig. 15 Market trends & outlook
Fig. 16 PESTEL analysis
Fig. 17 Porter’s five forces analysis
Fig. 18 Oligonucleotide synthesis market: Product & Services outlook & key takeaways
Fig. 19 Oligonucleotide synthesis market: Product & Services movement analysis
Fig. 20 Oligonucleotides market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 21 DNA market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 22 Column-based market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 23 Array-based market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 24 RNA market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 25 Column-based market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 26 Array-based market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 27 Short RNA Oligos (<65 nt) market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 28 Long RNA Oligos (>65 nt) market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 29 CRISPR (sgRNA) market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 30 Equipment/Synthesizer market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 31 Reagents market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 32 Services market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 33 DNA market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 34 Custom Oligo Synthesis Services market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 35 25 nmol market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 36 50 nmol market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 37 200 nmol market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 38 1000 nmol market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 39 10000 nmol market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 40 Modification Services market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 41 Purification Services market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 42 RNA market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 43 Oligo Synthesis Services market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 44 25 nmol market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 45 50 nmol market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 46 200 nmol market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 47 1000 nmol market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 48 10000 nmol market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 49 Modification Services market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 50 Purification Services market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 51 Oligonucleotide synthesis market: Application outlook key takeaways
Fig. 52 Oligonucleotide synthesis market: Application movement analysis
Fig. 53 PCR Primers oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 54 PCR Assays and Panels oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 55 Sequencing oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 56 DNA Microarrays oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 57 Fluorescence In Situ Hybridization (FISH) oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 58 Antisense Oligonucleotides oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 59 Other Applications oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 60 Oligonucleotide synthesis market: End use outlook key takeaways
Fig. 61 Oligonucleotide synthesis market: End use movement analysis
Fig. 62 Academic Research Institutes oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 63 Diagnostic Laboratories oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 64 Pharmaceutical - Biotechnology Companies oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 65 Regional outlook
Fig. 66 Regional marketplace: Key takeaways
Fig. 67 North America oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 68 Key country dynamics
Fig. 69 U.S. oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 70 Key country dynamics
Fig. 71 Canada oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 72 Key country dynamics
Fig. 73 Mexico oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 74 Europe oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 75 Key country dynamics
Fig. 76 Germany oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 77 Key country dynamics
Fig. 78 UK oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 79 Key country dynamics
Fig. 80 France oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 81 Key country dynamics
Fig. 82 Italy oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 83 Key country dynamics
Fig. 84 Spain oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 85 Key country dynamics
Fig. 86 Denmark oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 87 Key country dynamics
Fig. 88 Sweden oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 89 Key country dynamics
Fig. 90 Norway oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 91 Asia Pacific oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 92 Key country dynamics
Fig. 93 Japan oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 94 Key country dynamics
Fig. 95 China oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 96 Key country dynamics
Fig. 97 India oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 98 Key country dynamics
Fig. 99 Australia oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 100 Key country dynamics
Fig. 101 Thailand oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 102 Key country dynamics
Fig. 103 South Korea oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 104 Latin America oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 105 Key country dynamics
Fig. 106 Brazil oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 107 Key country dynamics
Fig. 108 Argentina oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 109 MEA oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 110 Key country dynamics
Fig. 111 South Africa oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 112 Key country dynamics
Fig. 113 Saudi Arabia oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 114 Key country dynamics
Fig. 115 UAE oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 116 Key country dynamics
Fig. 117 Kuwait oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)